PT-141 Peptide How to Use: Purity Specifications, Manufacturing Standards & Sourcing Guide for Labs

Core Molecular Specs & Technical Index

PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide developed for research into melanocortin receptor pathways. For B2B buyers—including cosmetic formulation labs, peptide research facilities, and bulk raw material distributors—understanding the precise technical specifications is the first step in evaluating pt-141 peptide how to use effectively in controlled environments. This molecule is supplied as a lyophilized powder, requiring reconstitution and strict handling protocols to maintain bioactivity.

• Molecular Formula & Weight: C50H68N14O10, exact mass 1025.52 g/mol; sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH.
• Purity Specification: Minimum 98% by HPLC (High-Performance Liquid Chromatography), with 99%+ available for premium research grades.
• Solubility Profile: Freely soluble in water (>20 mg/mL) and bacteriostatic water; limited solubility in organic solvents like DMSO.
• Storage Conditions: Lyophilized powder stable at -20°C for 24 months; reconstituted solution must be refrigerated at 2-8°C and used within 7 days.
• Appearance & pH: White to off-white amorphous powder; reconstituted solution pH typically 5.0-6.5 in water.

Industry data from the American Peptide Society indicates that over 70% of peptide research failures stem from improper reconstitution or storage protocols. For PT-141, maintaining a sterile environment and avoiding freeze-thaw cycles are critical to preserving the cyclic structure that defines its receptor-binding activity.

Manufacturing & Quality Control

Reliable sourcing of PT-141 requires rigorous oversight of the entire production chain, from solid-phase peptide synthesis (SPPS) to final lyophilization. Laboratories and cosmetic ingredient buyers must verify that their supplier adheres to Good Manufacturing Practice (GMP) standards and provides comprehensive third-party testing documentation.

Production Process

The manufacturing begins with SPPS using Fmoc chemistry, where amino acids are sequentially coupled to a resin support. After cleavage and deprotection, the crude peptide undergoes cyclization to form the essential lactam bridge between Asp and Lys residues. This step is critical for biological activity and must be monitored by analytical HPLC.

Purification & Testing

Preparative reverse-phase HPLC is employed to achieve target purity levels. Each batch is then subjected to mass spectrometry (MS) for identity confirmation and amino acid analysis for composition verification. Third-party laboratories perform independent assays for endotoxin levels (<1 EU/mg), residual solvents, and heavy metals.

• Certificate of Analysis (CoA): Provided with every batch, detailing purity percentage, retention time, and mass spectrum.
• Stability Studies: Accelerated stability data at 40°C/75% RH for 4 weeks to confirm shelf life.
• Batch Consistency: Inter-batch variability below 2% for purity and peptide content.

Commercial Application Scenarios

Understanding pt-141 peptide how to use in commercial settings requires differentiating between research, cosmetic formulation, and bulk distribution contexts. Each scenario demands specific handling and documentation protocols.

Cosmetic Formulation

In cosmetic labs, PT-141 is incorporated into topical serums or creams at concentrations typically ranging from 0.01% to 0.1%. The peptide must be first dissolved in a small volume of sterile water or a compatible solvent, then blended into the base formulation under aseptic conditions. Formulators must verify pH compatibility (ideal range 5.0-6.5) to prevent peptide degradation.

Lab Research

For in vitro or in vivo research, PT-141 is reconstituted with bacteriostatic water to a stock concentration of 1-10 mg/mL. Researchers aliquot the solution into single-use vials to avoid repeated freeze-thaw cycles. Dosing in animal models typically ranges from 0.1 to 1.0 mg/kg, administered subcutaneously or intraperitoneally.

Bulk Wholesale

Bulk buyers (1 kg or more) receive PT-141 in sealed, double-bagged containers with desiccant. The material is shipped on dry ice with temperature loggers. Buyers must have cold storage capacity at -20°C and a protocol for aliquotting upon receipt to maintain batch integrity.

pt-141 peptide how to use VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing PT-141 in bulk, B2B buyers must navigate common pitfalls to ensure they receive material that meets their specifications. The following checklist helps evaluate suppliers and avoid costly mistakes.

Common Pitfalls

• Undisclosed Impurities: Low-grade peptides may contain truncated sequences or oxidation byproducts that affect activity. Always request a full HPLC chromatogram.
• Incorrect Cyclization: PT-141 requires a specific lactam bridge. Suppliers using alternative cyclization methods may produce inactive analogs.
• Inadequate Packaging: Peptides are hygroscopic. Bulk containers without desiccant or vacuum sealing lead to moisture absorption and degradation.

Selection Standards

• Request Third-Party Testing: Insist on independent lab reports for purity, identity, and endotoxin levels.
• Verify Manufacturing Facility: Confirm GMP certification and audit history. Facilities with ISO 9001 or 13485 are preferred.
• Evaluate Lead Time: Reliable suppliers maintain stock for standard purities (98%) and can ship within 5-7 business days for bulk orders.

Buyer Checklist

• ☐ Certificate of Analysis with batch number and date
• ☐ HPLC chromatogram showing main peak and impurity profile
• ☐ Mass spectrometry confirmation of molecular weight
• ☐ Endotoxin and bioburden test results
• ☐ Storage and handling documentation
• ☐ Material Safety Data Sheet (MSDS)

Core Product Advantages

Our PT-141 peptide is manufactured under strict GMP conditions with a focus on four key advantages that directly benefit B2B buyers. First, purity consistency across batches ensures reproducible results in formulation and research. Second, stability optimization through lyophilization and packaging extends shelf life to 24 months at -20°C. Third, cost performance is achieved by minimizing waste through precise aliquotting and clear reconstitution protocols. Fourth, technical support from our in-house peptide chemists helps buyers troubleshoot formulation challenges or scale-up issues. For laboratories and cosmetic manufacturers, these advantages translate into lower total cost of ownership and higher confidence in end-product quality.

Frequently Asked Questions

Q: What is the recommended reconstitution protocol for PT-141 in a lab setting?
A: For research use, reconstitute lyophilized PT-141 with bacteriostatic water (0.9% benzyl alcohol) to a concentration of 1-10 mg/mL. Gently swirl the vial without vigorous shaking to avoid foaming. Use within 7 days if stored at 2-8°C, or aliquot and freeze at -20°C for longer storage. Always use sterile techniques to prevent contamination.

Q: How do I verify the purity of PT-141 from a new supplier?
A: Request a Certificate of Analysis that includes HPLC purity percentage, retention time, and a chromatogram. For independent verification, send a sample to a third-party analytical lab for HPLC-MS analysis. Look for a single main peak with no significant impurities (>0.5% area). Compare the mass spectrum to the theoretical molecular weight of 1025.52 g/mol.

Q: Can PT-141 be used in cosmetic formulations without additional processing?
A: Yes, but the peptide must be first dissolved in a small volume of sterile water or a compatible solvent before incorporation into the base formulation. The final product pH should be maintained between 5.0 and 6.5 to prevent peptide degradation. Cosmetic manufacturers should conduct stability testing on the finished formulation to ensure peptide activity is preserved over the product's shelf life.